You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M MEDRONATE KIT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for technetium tc-99m medronate kit

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03002454 ↗ Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo Terminated Winnipeg Regional Health Authority Phase 3 2016-08-01 A non-fission sourced, solvent generator produced 99mTc intravenous injection, as 99mTc -MDP, is to be used as a bone scan diagnostic radiopharmaceutical for assessment of bone pathology using the same oncologic indications as nuclear reactor sourced 99mTc, as 99mTc-MDP.
NCT03002454 ↗ Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo Terminated University of Manitoba Phase 3 2016-08-01 A non-fission sourced, solvent generator produced 99mTc intravenous injection, as 99mTc -MDP, is to be used as a bone scan diagnostic radiopharmaceutical for assessment of bone pathology using the same oncologic indications as nuclear reactor sourced 99mTc, as 99mTc-MDP.
NCT03707184 ↗ Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone Recruiting University of Utah Phase 2 2018-10-02 This trial studies how well fluciclovine 18F PET/CT imaging works in assessing hormone-naive men with prostate cancer that has spread to the bone. Fluciclovine 18F is a radioactive drug used to measure tumor growth. PET/CT uses x-rays to take pictures inside the body. Comparing results of fluciclovine 18F PET/CT imaging may help doctors predict a patient's response to treatment and help plan the best treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for technetium tc-99m medronate kit

Condition Name

Condition Name for technetium tc-99m medronate kit
Intervention Trials
Prostate Carcinoma Metastatic in the Bone 1
Stage IV Prostate Cancer 1
Cancer of Bone 1
Metastatic Prostate Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for technetium tc-99m medronate kit
Intervention Trials
Prostatic Neoplasms 1
Carcinoma 1
Bone Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for technetium tc-99m medronate kit

Trials by Country

Trials by Country for technetium tc-99m medronate kit
Location Trials
United States 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for technetium tc-99m medronate kit
Location Trials
Utah 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for technetium tc-99m medronate kit

Clinical Trial Phase

Clinical Trial Phase for technetium tc-99m medronate kit
Clinical Trial Phase Trials
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for technetium tc-99m medronate kit
Clinical Trial Phase Trials
Terminated 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for technetium tc-99m medronate kit

Sponsor Name

Sponsor Name for technetium tc-99m medronate kit
Sponsor Trials
Winnipeg Regional Health Authority 1
University of Manitoba 1
University of Utah 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for technetium tc-99m medronate kit
Sponsor Trials
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.